Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

xMD-miRNA-seq to generate near in vivo miRNA expression estimates in colon epithelial cells.

Rosenberg AZ, Wright C, Fox-Talbot K, Rajpurohit A, Williams C, Porter C, Kovbasnjuk O, McCall MN, Shin JH, Halushka MK.

Sci Rep. 2018 Jun 28;8(1):9783. doi: 10.1038/s41598-018-28198-z.

2.

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.

Kumar B, Rosenberg AZ, Choi SM, Fox-Talbot K, De Marzo AM, Nonn L, Brennen WN, Marchionni L, Halushka MK, Lupold SE.

Sci Rep. 2018 May 8;8(1):7189. doi: 10.1038/s41598-018-25320-z.

3.

Cardiomyocytes have mosaic patterns of protein expression.

Wang TY, Lee D, Fox-Talbot K, Arking DE, Chakravarti A, Halushka MK.

Cardiovasc Pathol. 2018 May - Jun;34:50-57. doi: 10.1016/j.carpath.2018.03.002. Epub 2018 Mar 24.

4.

An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.

Kapoor A, Sekar RB, Hansen NF, Fox-Talbot K, Morley M, Pihur V, Chatterjee S, Brandimarto J, Moravec CS, Pulit SL; QT Interval-International GWAS Consortium, Pfeufer A, Mullikin J, Ross M, Green ED, Bentley D, Newton-Cheh C, Boerwinkle E, Tomaselli GF, Cappola TP, Arking DE, Halushka MK, Chakravarti A.

Am J Hum Genet. 2014 Jun 5;94(6):854-69. doi: 10.1016/j.ajhg.2014.05.001. Epub 2014 May 22.

5.

Evidence for classic complement activity in neuromyelitis optica.

Jones MV, Fox-Talbot K, Levy M.

Clin Neuropathol. 2014 May-Jun;33(3):251-2. doi: 10.5414/NP300697. No abstract available.

6.

Strengthening the skin with topical delivery of keratinocyte growth factor-1 using a novel DNA plasmid.

Dou C, Lay F, Ansari AM, Rees DJ, Ahmed AK, Kovbasnjuk O, Matsangos AE, Du J, Hosseini SM, Steenbergen C, Fox-Talbot K, Tabor AT, Williams JA, Liu L, Marti GP, Harmon JW.

Mol Ther. 2014 Apr;22(4):752-61. doi: 10.1038/mt.2014.2. Epub 2014 Jan 17.

7.

Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition.

Ferlito M, Wang Q, Fulton WB, Colombani PM, Marchionni L, Fox-Talbot K, Paolocci N, Steenbergen C.

J Immunol. 2014 Feb 15;192(4):1806-14. doi: 10.4049/jimmunol.1300835. Epub 2014 Jan 8. Erratum in: J Immunol. 2014 Apr 15;192(8):3991.

8.

Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients.

Erdinc Sunay MM, Fox-Talbot K, Velidedeoglu E, Baldwin WM 3rd, Wasowska BA.

Transplantation. 2013 Oct 15;96(7):601-8. doi: 10.1097/TP.0b013e31829c2455.

9.

A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies.

Briassouli P, Halushka MK, Reed JH, Molad Y, Fox-Talbot K, Buyon L, Guzman E, Ludomirsky A, Clancy RM, Buyon JP.

Rheumatology (Oxford). 2013 Aug;52(8):1448-53. doi: 10.1093/rheumatology/ket156. Epub 2013 Apr 18.

10.

Sildenafil citrate protects skeletal muscle of ischemia-reperfusion injury: immunohistochemical study in rat model.

Armstrong DM, Armstrong Ada C, Figueiredo RC, Florentino JE, Saad PF, Fox-Talbot K, Halushka MK, Berkowitz DE, Taha MO, Fagundes DJ.

Acta Cir Bras. 2013 Apr;28(4):282-7.

11.

Integration and regression of implanted engineered human vascular networks during deep wound healing.

Hanjaya-Putra D, Shen YI, Wilson A, Fox-Talbot K, Khetan S, Burdick JA, Steenbergen C, Gerecht S.

Stem Cells Transl Med. 2013 Apr;2(4):297-306. doi: 10.5966/sctm.2012-0111. Epub 2013 Mar 13.

12.

Beneficial cardiac effects of caloric restriction are lost with age in a murine model of obesity.

AlGhatrif M, Watts VL, Niu X, Halushka M, Miller KL, Vandegaer K, Bedja D, Fox-Talbot K, Bielawska A, Gabrielson KL, Barouch LA.

J Cardiovasc Transl Res. 2013 Jun;6(3):436-45. doi: 10.1007/s12265-013-9453-4. Epub 2013 Mar 2.

PMID:
23456569
13.

RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.

Kent OA, Fox-Talbot K, Halushka MK.

Oncogene. 2013 May 16;32(20):2576-85. doi: 10.1038/onc.2012.266. Epub 2012 Jul 2.

PMID:
22751122
14.

Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning.

Sarkar K, Cai Z, Gupta R, Parajuli N, Fox-Talbot K, Darshan MS, Gonzalez FJ, Semenza GL.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10504-9. doi: 10.1073/pnas.1208314109. Epub 2012 Jun 13.

15.

Nuclear miRNA regulates the mitochondrial genome in the heart.

Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E, Steenbergen C.

Circ Res. 2012 Jun 8;110(12):1596-603. doi: 10.1161/CIRCRESAHA.112.267732. Epub 2012 Apr 19.

16.

Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling.

Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K, Rouf R, Chen S, Steenbergen C, Harmon JW, Dietz HC, Gabrielson KL, Kass DA, Semenza GL.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):E841-50. doi: 10.1073/pnas.1202081109. Epub 2012 Mar 8.

17.

Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.

Giles JT, Fert-Bober J, Park JK, Bingham CO 3rd, Andrade F, Fox-Talbot K, Pappas D, Rosen A, van Eyk J, Bathon JM, Halushka MK.

Arthritis Res Ther. 2012 Feb 24;14(1):R39. doi: 10.1186/ar3752.

18.

Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing.

Sun G, Zhang X, Shen YI, Sebastian R, Dickinson LE, Fox-Talbot K, Reinblatt M, Steenbergen C, Harmon JW, Gerecht S.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):20976-81. doi: 10.1073/pnas.1115973108. Epub 2011 Dec 14.

19.

MicroRNA profiling of diverse endothelial cell types.

McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK.

BMC Med Genomics. 2011 Nov 2;4:78. doi: 10.1186/1755-8794-4-78.

20.

Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells.

Sarkar K, Rey S, Zhang X, Sebastian R, Marti GP, Fox-Talbot K, Cardona AV, Du J, Tan YS, Liu L, Lay F, Gonzalez FJ, Harmon JW, Semenza GL.

Cardiovasc Res. 2012 Jan 1;93(1):162-9. doi: 10.1093/cvr/cvr282. Epub 2011 Oct 25.

21.

A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.

Alvarez D, Briassouli P, Clancy RM, Zavadil J, Reed JH, Abellar RG, Halushka M, Fox-Talbot K, Barrat FJ, Buyon JP.

J Biol Chem. 2011 Sep 2;286(35):30444-54. doi: 10.1074/jbc.M111.263657. Epub 2011 Jul 5.

22.

Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix.

Hanjaya-Putra D, Bose V, Shen YI, Yee J, Khetan S, Fox-Talbot K, Steenbergen C, Burdick JA, Gerecht S.

Blood. 2011 Jul 21;118(3):804-15. doi: 10.1182/blood-2010-12-327338. Epub 2011 Apr 28.

23.

Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds.

Zhang X, Sarkar K, Rey S, Sebastian R, Andrikopoulou E, Marti GP, Fox-Talbot K, Semenza GL, Harmon JW.

J Mol Med (Berl). 2011 Oct;89(10):985-95. doi: 10.1007/s00109-011-0754-2. Epub 2011 Apr 16.

24.

Caloric restriction in leptin deficiency does not correct myocardial steatosis: failure to normalize PPAR{alpha}/PGC1{alpha} and thermogenic glycerolipid/fatty acid cycling.

Rame JE, Barouch LA, Sack MN, Lynn EG, Abu-Asab M, Tsokos M, Kern SJ, Barb JJ, Munson PJ, Halushka MK, Miller KL, Fox-Talbot K, Zhang J, Hare JM, Solomon MA, Danner RL.

Physiol Genomics. 2011 Jun 28;43(12):726-38. doi: 10.1152/physiolgenomics.00088.2010. Epub 2011 Mar 22.

25.

Platelets contribute to allograft rejection through glutamate receptor signaling.

Swaim AF, Field DJ, Fox-Talbot K, Baldwin WM 3rd, Morrell CN.

J Immunol. 2010 Dec 1;185(11):6999-7006. doi: 10.4049/jimmunol.1000929. Epub 2010 Oct 20.

26.

Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors.

Sun G, Shen YI, Kusuma S, Fox-Talbot K, Steenbergen CJ, Gerecht S.

Biomaterials. 2011 Jan;32(1):95-106. doi: 10.1016/j.biomaterials.2010.08.091. Epub 2010 Sep 25.

PMID:
20870284
27.

B cells and plasma cells in coronaries of chronically rejected cardiac transplants.

Wehner JR, Fox-Talbot K, Halushka MK, Ellis C, Zachary AA, Baldwin WM 3rd.

Transplantation. 2010 May 15;89(9):1141-8. doi: 10.1097/TP.0b013e3181d3f271.

28.

Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice.

Zu L, Bedja D, Fox-Talbot K, Gabrielson KL, Van Kaer L, Becker LC, Cai ZP.

J Mol Cell Cardiol. 2010 Jul;49(1):5-15. doi: 10.1016/j.yjmcc.2010.02.007. Epub 2010 Feb 12.

29.

Lymphatic injury and regeneration in cardiac allografts.

Soong TR, Pathak AP, Asano H, Fox-Talbot K, Baldwin WM 3rd.

Transplantation. 2010 Mar 15;89(5):500-8. doi: 10.1097/TP.0b013e3181c73c34. Erratum in: Transplantation. 2010 Dec 15;90(11):1244.

30.

Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice.

Sarkar K, Fox-Talbot K, Steenbergen C, Bosch-Marcé M, Semenza GL.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18769-74. doi: 10.1073/pnas.0910561106. Epub 2009 Oct 19. Erratum in: Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):513.

31.

CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells.

Choy JC, Yi T, Rao DA, Tellides G, Fox-Talbot K, Baldwin WM 3rd, Pober JS.

J Heart Lung Transplant. 2008 Dec;27(12):1333-9. doi: 10.1016/j.healun.2008.08.014.

32.

Platelet factor 4 mediates inflammation in experimental cerebral malaria.

Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, Shirk EM, Sun H, Kowalska MA, Fox-Talbot K, Sullivan D, Zavala F, Morrell CN.

Cell Host Microbe. 2008 Aug 14;4(2):179-87. doi: 10.1016/j.chom.2008.07.003.

33.

C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation.

Murata K, Iwata T, Nakashima S, Fox-Talbot K, Qian Z, Wilkes DS, Baldwin WM.

Transplantation. 2008 Jul 15;86(1):123-9. doi: 10.1097/TP.0b013e31817b0b57.

34.

In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody.

Morrell CN, Murata K, Swaim AM, Mason E, Martin TV, Thompson LE, Ballard M, Fox-Talbot K, Wasowska B, Baldwin WM 3rd.

Circ Res. 2008 Apr 11;102(7):777-85. doi: 10.1161/CIRCRESAHA.107.170332. Epub 2008 Feb 22.

PMID:
18296616
35.

The involvement of FcR mechanisms in antibody-mediated rejection.

Lee CY, Lotfi-Emran S, Erdinc M, Murata K, Velidedeoglu E, Fox-Talbot K, Liu J, Garyu J, Baldwin WM 3rd, Wasowska BA.

Transplantation. 2007 Nov 27;84(10):1324-34.

PMID:
18049118
36.

Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha.

Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL.

Cardiovasc Res. 2008 Feb 1;77(3):463-70. Epub 2007 Oct 11.

PMID:
18006459
37.

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.

Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner S, Keil S, Goodrich RP, Baldwin WM 3rd.

Transplantation. 2007 Nov 15;84(9):1174-82.

PMID:
17998874
38.

Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.

Yang XP, Mattagajasingh S, Su S, Chen G, Cai Z, Fox-Talbot K, Irani K, Becker LC.

Circ Res. 2007 Nov 9;101(10):1001-8. Epub 2007 Sep 20.

PMID:
17885215
39.

Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants.

Murata K, Fox-Talbot K, Qian Z, Takahashi K, Stahl GL, Baldwin WM 3rd, Wasowska BA.

Am J Transplant. 2007 Nov;7(11):2605-14. Epub 2007 Sep 14.

40.

Robust immunohistochemical staining of several classes of proteins in tissues subjected to autolysis.

Maleszewski J, Lu J, Fox-Talbot K, Halushka MK.

J Histochem Cytochem. 2007 Jun;55(6):597-606. Epub 2007 Feb 20.

PMID:
17312010
41.

Antibody to human leukocyte antigen triggers endothelial exocytosis.

Yamakuchi M, Kirkiles-Smith NC, Ferlito M, Cameron SJ, Bao C, Fox-Talbot K, Wasowska BA, Baldwin WM 3rd, Pober JS, Lowenstein CJ.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1301-6. Epub 2007 Jan 17.

42.

Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.

Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC.

J Cardiovasc Pharmacol. 2006 Dec;48(6):320-8.

PMID:
17204912
43.

Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion.

Qian Z, Lee CY, Murata K, Liu J, Fox-Talbot K, Wasowska BA, Baldwin WM 3rd.

Transplantation. 2006 Oct 15;82(7):857-64.

PMID:
17038898
44.

C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats.

Minami K, Murata K, Lee CY, Fox-Talbot K, Wasowska BA, Pescovitz MD, Baldwin WM 3rd.

Am J Transplant. 2006 May;6(5 Pt 1):923-32.

45.

Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium.

Yang XP, Irani K, Mattagajasingh S, Dipaula A, Khanday F, Ozaki M, Fox-Talbot K, Baldwin WM 3rd, Becker LC.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1395-400. Epub 2005 Apr 28.

PMID:
15860735
46.

A rat model of pregnancy-induced sensitization to transplants.

Qian Z, Liu J, Fox-Talbot K, Wasowska BA, Baldwin WM 3rd.

Transplant Proc. 2005 Jan-Feb;37(1):96-7.

PMID:
15808559
47.

Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.

Nakashima S, Soong TR, Fox-Talbot K, Qian Z, Rahimi S, Wasowska BA, Rohde CA, Chen S, Garcia JG, Baldwin WM 3rd.

Am J Transplant. 2005 Apr;5(4 Pt 1):694-701.

48.

Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts.

Ota H, Fox-Talbot K, Hu W, Qian Z, Sanfilippo F, Hruban RH, Baldwin WM 3rd.

Transplantation. 2005 Feb 15;79(3):276-81.

PMID:
15699756
49.

Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry.

Padalko E, Ohnishi T, Matsushita K, Sun H, Fox-Talbot K, Bao C, Baldwin WM 3rd, Lowenstein CJ.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11731-6. Epub 2004 Jul 30.

50.

Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts.

Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM 3rd, Wasowska BA.

Am J Transplant. 2004 Mar;4(3):326-34.

Supplemental Content

Loading ...
Support Center